_id
69130111ccc777a4e85d7905
Ticker
IMA
Name
ImageneBio, Inc.
Exchange
NASDAQ
Address
12526 High Bluff Drive, San Diego, CA, United States, 92130
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.inmagenebio.com
Description
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
Last Close
7.0295
Volume
18713
Current Price
6.886
Change
-0.14
Last Updated
2026-01-04T15:08:25.757Z
Image
data:image/webp;base64,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
Ipo Date
2021-03-26T00:00:00.000Z
Market Cap
91689744
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.997
Sentiment Sources
1
Rating
4
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
26594000
Operating Income
-26594000
Interest Expense
96000
Pretax Income
-24853000
Net Income
-24779000
Eps
-2.906020454846911
Dividends Per Share
-
Shares Outstanding
11181676
Income Tax Expense
-74000
EBITDA
-24757000
Operating Margin
-
Total Other Income Expense Net
1741000
Cash
103162000
Short Term Investments
39421000
Receivables
728000
Inventories
-
Total Current Assets
147532000
Property Plant Equipment
885000
Total Assets
160878000
Payables
2081000
Short Term Debt
2161000
Long Term Debt
-
Total Liabilities
21046000
Equity
139832000
Bs_currency_symbol
USD
Depreciation
-201000
Change In Working Capital
-13339000
Cash From Operations
-26642000
Capital Expenditures
0
Cash From Investing
-37331000
Cash From Financing
135468000
Net Change In Cash
44872000
Cf_currency_symbol
USD
PE
-
PB
0.41989969367526747
ROE
-17.720550374735396
ROA
-15.402354579246385
FCF
-26642000
Fcf Percent
-
Piotroski FScore
0
Health Score
41
Deep Value Investing Score
7
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
7
Quality Investing Score
3
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
26594000
Quarters > 0 > income Statement > operating Income
-26594000
Quarters > 0 > income Statement > interest Expense
96000
Quarters > 0 > income Statement > pretax Income
-24853000
Quarters > 0 > income Statement > net Income
-24779000
Quarters > 0 > income Statement > eps
-2.906020454846911
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
8526781
Quarters > 0 > income Statement > income Tax Expense
-74000
Quarters > 0 > income Statement > EBITDA
-24757000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1741000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
103162000
Quarters > 0 > balance Sheet > short Term Investments
39421000
Quarters > 0 > balance Sheet > receivables
728000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
147532000
Quarters > 0 > balance Sheet > property Plant Equipment
885000
Quarters > 0 > balance Sheet > total Assets
160878000
Quarters > 0 > balance Sheet > payables
2081000
Quarters > 0 > balance Sheet > short Term Debt
2161000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
21046000
Quarters > 0 > balance Sheet > equity
139832000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-24779000
Quarters > 0 > cash Flow > depreciation
-201000
Quarters > 0 > cash Flow > change In Working Capital
-13339000
Quarters > 0 > cash Flow > cash From Operations
-26642000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-37331000
Quarters > 0 > cash Flow > cash From Financing
135468000
Quarters > 0 > cash Flow > net Change In Cash
44872000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-2.906020454846911
Quarters > 0 > ratios > PB
0.41989969367526747
Quarters > 0 > ratios > ROE
-17.720550374735396
Quarters > 0 > ratios > ROA
-15.402354579246385
Quarters > 0 > ratios > FCF
-26642000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
45000
Quarters > 1 > income Statement > gross Profit
-45000
Quarters > 1 > income Statement > operating Expenses
8705000
Quarters > 1 > income Statement > operating Income
-8750000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-2752000
Quarters > 1 > income Statement > net Income
-2767000
Quarters > 1 > income Statement > eps
-0.05733751161540492
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
48258111
Quarters > 1 > income Statement > income Tax Expense
15000
Quarters > 1 > income Statement > EBITDA
-8353999
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
5998000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
58290000
Quarters > 1 > balance Sheet > short Term Investments
37352000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
99013000
Quarters > 1 > balance Sheet > property Plant Equipment
2980000
Quarters > 1 > balance Sheet > total Assets
126166000
Quarters > 1 > balance Sheet > payables
512000
Quarters > 1 > balance Sheet > short Term Debt
3834000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
10259000
Quarters > 1 > balance Sheet > equity
115907000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-2767000
Quarters > 1 > cash Flow > depreciation
87000
Quarters > 1 > cash Flow > change In Working Capital
-1694000
Quarters > 1 > cash Flow > cash From Operations
-3422000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
24949000
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
21527000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.05733751161540492
Quarters > 1 > ratios > PB
2.8669998563158394
Quarters > 1 > ratios > ROE
-2.3872587505500102
Quarters > 1 > ratios > ROA
-2.1931423679913764
Quarters > 1 > ratios > FCF
-3422000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
3715000
Quarters > 2 > income Statement > gross Profit
-3715000
Quarters > 2 > income Statement > operating Expenses
7079000
Quarters > 2 > income Statement > operating Income
-10794000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-8591000
Quarters > 2 > income Statement > net Income
-8619000
Quarters > 2 > income Statement > eps
-0.17860210069142574
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
48258111
Quarters > 2 > income Statement > income Tax Expense
28000
Quarters > 2 > income Statement > EBITDA
-9272000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
2203000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
36763000
Quarters > 2 > balance Sheet > short Term Investments
77288000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
116999000
Quarters > 2 > balance Sheet > property Plant Equipment
3608000
Quarters > 2 > balance Sheet > total Assets
130838000
Quarters > 2 > balance Sheet > payables
805000
Quarters > 2 > balance Sheet > short Term Debt
3892000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
12588000
Quarters > 2 > balance Sheet > equity
118250000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-8619000
Quarters > 2 > cash Flow > depreciation
87000
Quarters > 2 > cash Flow > change In Working Capital
-3271000
Quarters > 2 > cash Flow > cash From Operations
-10562000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
7932000
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-2630000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.17860210069142574
Quarters > 2 > ratios > PB
2.8101932545116277
Quarters > 2 > ratios > ROE
-7.288794926004229
Quarters > 2 > ratios > ROA
-6.587535731209587
Quarters > 2 > ratios > FCF
-10562000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
4580000
Quarters > 3 > income Statement > gross Profit
-4580000
Quarters > 3 > income Statement > operating Expenses
7937000
Quarters > 3 > income Statement > operating Income
-12517000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-9071000
Quarters > 3 > income Statement > net Income
-9124000
Quarters > 3 > income Statement > eps
-0.18906666280410353
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
48258111
Quarters > 3 > income Statement > income Tax Expense
53000
Quarters > 3 > income Statement > EBITDA
-12086000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
3446000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
39393000
Quarters > 3 > balance Sheet > short Term Investments
84993000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
127169000
Quarters > 3 > balance Sheet > property Plant Equipment
4228000
Quarters > 3 > balance Sheet > total Assets
141510000
Quarters > 3 > balance Sheet > payables
897000
Quarters > 3 > balance Sheet > short Term Debt
3784000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
15576000
Quarters > 3 > balance Sheet > equity
125934000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-9124000
Quarters > 3 > cash Flow > depreciation
89000
Quarters > 3 > cash Flow > change In Working Capital
1537000
Quarters > 3 > cash Flow > cash From Operations
-6260000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
463000
Quarters > 3 > cash Flow > cash From Financing
6906000
Quarters > 3 > cash Flow > net Change In Cash
-5797000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.18906666280410353
Quarters > 3 > ratios > PB
2.6387262561818097
Quarters > 3 > ratios > ROE
-7.245064875252116
Quarters > 3 > ratios > ROA
-6.447600876263161
Quarters > 3 > ratios > FCF
-6260000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
43
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
3500000
Annuals > 0 > income Statement > cost Of Revenue
490000
Annuals > 0 > income Statement > gross Profit
3500000
Annuals > 0 > income Statement > operating Expenses
40500000
Annuals > 0 > income Statement > operating Income
-37000000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-36555000
Annuals > 0 > income Statement > net Income
-36568000
Annuals > 0 > income Statement > eps
-0.7577603713373948
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
48258000
Annuals > 0 > income Statement > income Tax Expense
13000
Annuals > 0 > income Statement > EBITDA
-35474000
Annuals > 0 > income Statement > operating Margin
-1057.142857142857
Annuals > 0 > income Statement > total Other Income Expense Net
445000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
39393000
Annuals > 0 > balance Sheet > short Term Investments
84993000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
127169000
Annuals > 0 > balance Sheet > property Plant Equipment
4228000
Annuals > 0 > balance Sheet > total Assets
141510000
Annuals > 0 > balance Sheet > payables
897000
Annuals > 0 > balance Sheet > short Term Debt
3784000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
15576000
Annuals > 0 > balance Sheet > equity
125934000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-49234000
Annuals > 0 > cash Flow > depreciation
490000
Annuals > 0 > cash Flow > change In Working Capital
-3979000
Annuals > 0 > cash Flow > cash From Operations
-46004000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-34903000
Annuals > 0 > cash Flow > cash From Financing
6906000
Annuals > 0 > cash Flow > net Change In Cash
-80907000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.7577603713373948
Annuals > 0 > ratios > PB
2.590436895516699
Annuals > 0 > ratios > ROE
-29.037432305810977
Annuals > 0 > ratios > ROA
-25.841283301533462
Annuals > 0 > ratios > FCF
-46004000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-13.144
Annuals > 0 > health Score
35
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
9160000
Annuals > 1 > income Statement > cost Of Revenue
1020000
Annuals > 1 > income Statement > gross Profit
8140000
Annuals > 1 > income Statement > operating Expenses
83557000
Annuals > 1 > income Statement > operating Income
-75417000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-68328000
Annuals > 1 > income Statement > net Income
-68166000
Annuals > 1 > income Statement > eps
-1.633302209237356
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
41735081
Annuals > 1 > income Statement > income Tax Expense
-162000
Annuals > 1 > income Statement > EBITDA
-74397000
Annuals > 1 > income Statement > operating Margin
-823.329694323144
Annuals > 1 > income Statement > total Other Income Expense Net
7089000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
119894000
Annuals > 1 > balance Sheet > short Term Investments
55571000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
178662000
Annuals > 1 > balance Sheet > property Plant Equipment
8021000
Annuals > 1 > balance Sheet > total Assets
192092000
Annuals > 1 > balance Sheet > payables
2066000
Annuals > 1 > balance Sheet > short Term Debt
3558000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
22335000
Annuals > 1 > balance Sheet > equity
169757000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-68166000
Annuals > 1 > cash Flow > depreciation
1020000
Annuals > 1 > cash Flow > change In Working Capital
-21669000
Annuals > 1 > cash Flow > cash From Operations
-79743000
Annuals > 1 > cash Flow > capital Expenditures
414000
Annuals > 1 > cash Flow > cash From Investing
64144000
Annuals > 1 > cash Flow > cash From Financing
75980000
Annuals > 1 > cash Flow > net Change In Cash
59975000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.633302209237356
Annuals > 1 > ratios > PB
1.661958844465913
Annuals > 1 > ratios > ROE
-40.155045152777205
Annuals > 1 > ratios > ROA
-35.48612123357558
Annuals > 1 > ratios > FCF
-80157000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-8.750764192139737
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
15618000
Annuals > 2 > income Statement > cost Of Revenue
64321000
Annuals > 2 > income Statement > gross Profit
-48703000
Annuals > 2 > income Statement > operating Expenses
22201000
Annuals > 2 > income Statement > operating Income
-70904000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-68765000
Annuals > 2 > income Statement > net Income
-68765000
Annuals > 2 > income Statement > eps
-1.9001934873089237
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
36188420
Annuals > 2 > income Statement > income Tax Expense
-2139000
Annuals > 2 > income Statement > EBITDA
-70153000
Annuals > 2 > income Statement > operating Margin
-453.98898706620565
Annuals > 2 > income Statement > total Other Income Expense Net
2139000
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
59919000
Annuals > 2 > balance Sheet > short Term Investments
97028000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
160010000
Annuals > 2 > balance Sheet > property Plant Equipment
8460000
Annuals > 2 > balance Sheet > total Assets
172259000
Annuals > 2 > balance Sheet > payables
2093000
Annuals > 2 > balance Sheet > short Term Debt
1907000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
25290000
Annuals > 2 > balance Sheet > equity
146969000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-68765000
Annuals > 2 > cash Flow > depreciation
751000
Annuals > 2 > cash Flow > change In Working Capital
-15138000
Annuals > 2 > cash Flow > cash From Operations
-74109000
Annuals > 2 > cash Flow > capital Expenditures
1431000
Annuals > 2 > cash Flow > cash From Investing
-99284000
Annuals > 2 > cash Flow > cash From Financing
1095000
Annuals > 2 > cash Flow > net Change In Cash
-172298000
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
-1.9001934873089237
Annuals > 2 > ratios > PB
1.6645259830304349
Annuals > 2 > ratios > ROE
-46.78877858596031
Annuals > 2 > ratios > ROA
-39.91953976279904
Annuals > 2 > ratios > FCF
-75540000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-4.836726853630426
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
30985000
Annuals > 3 > income Statement > cost Of Revenue
47108000
Annuals > 3 > income Statement > gross Profit
-16123000
Annuals > 3 > income Statement > operating Expenses
18015000
Annuals > 3 > income Statement > operating Income
-34138000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-34115000
Annuals > 3 > income Statement > net Income
-34115000
Annuals > 3 > income Statement > eps
-0.9482965325342013
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
35975034
Annuals > 3 > income Statement > income Tax Expense
307442
Annuals > 3 > income Statement > EBITDA
-33594000
Annuals > 3 > income Statement > operating Margin
-110.17589156043246
Annuals > 3 > income Statement > total Other Income Expense Net
23000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
232217000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
236516000
Annuals > 3 > balance Sheet > property Plant Equipment
8977000
Annuals > 3 > balance Sheet > total Assets
247879000
Annuals > 3 > balance Sheet > payables
2384000
Annuals > 3 > balance Sheet > short Term Debt
1851000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
40002000
Annuals > 3 > balance Sheet > equity
207877000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-34115000
Annuals > 3 > cash Flow > depreciation
544000
Annuals > 3 > cash Flow > change In Working Capital
-33032000
Annuals > 3 > cash Flow > cash From Operations
-60252000
Annuals > 3 > cash Flow > capital Expenditures
1760000
Annuals > 3 > cash Flow > cash From Investing
-1760000
Annuals > 3 > cash Flow > cash From Financing
131738000
Annuals > 3 > cash Flow > net Change In Cash
69726000
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.9482965325342013
Annuals > 3 > ratios > PB
1.1698804092804878
Annuals > 3 > ratios > ROE
-16.41114697633697
Annuals > 3 > ratios > ROA
-13.7627632836989
Annuals > 3 > ratios > FCF
-62012000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-2.0013554945941583
Annuals > 3 > health Score
35
Valuation > metrics > PE
-2.906020454846911
Valuation > metrics > PB
0.41989969367526747
Valuation > final Score
70
Valuation > verdict
58.0% Undervalued
Profitability > metrics > ROE
-17.720550374735396
Profitability > metrics > ROA
-16.795678225740858
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.15050918244750844
Risk > metrics > Interest Coverage
-277.0208333333333
Risk > final Score
-1048
Risk > verdict
High
Liquidity > metrics > Current Ratio
34.77887788778878
Liquidity > metrics > Quick Ratio
34.77887788778878
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
54
Prev Risks > 1
-3
Prev Risks > 2
43
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:01:31.727Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-12
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-2.91
Earnings History > 0 > eps Estimate
-1
Earnings History > 0 > eps Difference
-1.91
Earnings History > 0 > surprise Percent
-191
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-24
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.69
Earnings History > 1 > eps Estimate
-0.1417
Earnings History > 1 > eps Difference
-0.5483
Earnings History > 1 > surprise Percent
-386.9442
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.17
Earnings History > 2 > eps Estimate
-0.1919
Earnings History > 2 > eps Difference
0.0219
Earnings History > 2 > surprise Percent
11.4122
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-06
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.2
Earnings History > 3 > eps Estimate
-0.2067
Earnings History > 3 > eps Difference
0.0067
Earnings History > 3 > surprise Percent
3.2414
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.21
Earnings History > 4 > eps Estimate
-0.2549
Earnings History > 4 > eps Difference
0.0449
Earnings History > 4 > surprise Percent
17.6148
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-09
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.28
Earnings History > 5 > eps Estimate
-0.36
Earnings History > 5 > eps Difference
0.08
Earnings History > 5 > surprise Percent
22.2222
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-13
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.33
Earnings History > 6 > eps Estimate
-0.33
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
0
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-12
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.41
Earnings History > 7 > eps Estimate
-0.41
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.4
Earnings History > 8 > eps Estimate
-0.4
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.44
Earnings History > 9 > eps Estimate
-0.44
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.39
Earnings History > 10 > eps Estimate
-0.39
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-14
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.39
Earnings History > 11 > eps Estimate
-0.39
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-07
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.48
Earnings History > 12 > eps Estimate
-0.48
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.57
Earnings History > 13 > eps Estimate
-0.57
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.47
Earnings History > 14 > eps Estimate
-0.47
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-17
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
0.07
Earnings History > 15 > eps Estimate
0.07
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.4
Earnings History > 16 > eps Estimate
-0.42
Earnings History > 16 > eps Difference
0.02
Earnings History > 16 > surprise Percent
4.7619
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-12
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-1.89
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-2.52
Earnings History > 18 > eps Estimate
-0.8713
Earnings History > 18 > eps Difference
-1.6487
Earnings History > 18 > surprise Percent
-189.223
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-03
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-0.15
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.15
Earnings History > 19 > surprise Percent
-
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ADB Securities raised its target stock price from 25,000 won to 30,000 won on the 20th, saying NH Inv.. 매일경제
Read more →[Click e-Stock] "NH Investment & Securities: Solid Earnings and Dividend Expectations... Target Price Up" 아시아경제
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of ImageneBio, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-2.91
EPS Estimate
-1
EPS Difference
-1.91
Surprise Percent
-191%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.